Gerhard Traxler

Linz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Application of optical coherence tomography in multiple sclerosis: consensus recommendations of the Austrian network (AN-OCT-MS).

Application of optical coherence tomography in multiple sclerosis: consensus recommendations of the Austrian network (AN-OCT-MS).

Journal: Journal of neurology

Published: October 24, 2025

Title Not Found

Title Not Found

Journal: Wiener klinische Wochenschrift

Published: December 16, 2024

Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC score.

Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC score.

Journal: Multiple sclerosis and related disorders

Published: November 29, 2024

Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome.

Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome.

Journal: European journal of neurology

Published: October 14, 2024

Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024

Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024

Journal: Wiener klinische Wochenschrift

Published: August 28, 2024

Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity.

Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity.

Journal: Neurology

Published: August 28, 2024

Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis.

Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: June 14, 2024

Impact of vaccination on COVID-19 outcome in multiple sclerosis.

Impact of vaccination on COVID-19 outcome in multiple sclerosis.

Journal: European journal of neurology

Published: July 06, 2022

Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study.

Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study.

Journal: Multiple sclerosis and related disorders

Published: May 15, 2022

Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.

Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.

Journal: European journal of neurology

Published: May 03, 2022

Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study.

Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study.

Journal: European journal of neurology

Published: December 06, 2021

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study.

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 01, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026